Hilary Kramer

Hilary Kramer

Hilary Kramer is one of Wall Street’s most successful equity analysts and investment managers, with a reputation as a leading expert on today’s market movements, stock trends and economic outlook.

She received her MBA from the Wharton School at the University of Pennsylvania and her BA from Wellesley College with honors. Hilary Kramer got her start on Wall Street more than two decades ago at Lehman Brothers and Morgan Stanley where she was an analyst in the investment banking group covering natural resources, diversified industrials and energy companies. She was also the chief investment officer of a family office — overseeing a $5.2 billion global private equity and publicly-traded equity fund, and co-vice chairman of the $500 million Ibero-American Partners Fund (1997 to 2003).

In 2004, Hilary’s A&G Capital formed a specialized research arm and investment fund. The GreenTech 21st Century Master Fund focused on companies engaged in alternative energy, clean technologies, environmental infrastructure and services, agricultural and natural resources.

Today, Hilary Kramer is an in-demand commentator whose work often appears in investing publications such as the Wall Street Journal, New York Post, Bloomberg, Business Insider and Reuters and is a regular on CNBC, CNN and the Fox News Channel, providing stock market insight and economic observations.

Hilary Kramer is also the editor of several financial advisory services designed to help individual investors profit from her stock picking talents: Value Authority, GameChangers, Breakout Stocks, High Octane Trader, Absolute Capital Return, Inner Circle and Inner Circle Pro.

Recent Articles

Has Apple Inc. Stock Finally Gotten Its Groove Back? (AAPL)

Apple stock may still have growth in its future, but if you're expecting the AAPL of old, you will probably be disappointed.

GoPro Inc: Has GPRO Stock Gone as Low as It Will Go?

GoPro's (GRPO) lack of urgency, especially when combined with questionable management, questionable fundamentals and a whole lot of competition, should be more than enough to make you stay away.

Biogen Inc (BIIB) Spinout: A Graceful Exit for the Hemophilia Biz

BIIB stock is letting its hemophilia business try to stand on its own, but this may be more to help Biogen than because the new spinoff will thrive.

Amazon.com, Inc.: AMZN Stock Packs on Even MORE Muscle With New Streaming Service

Amazon's new streaming service should be a worthy competitor in the growing streaming space, which means continued growth for AMZN stock.

IMAX Corporation (USA): Long-Term, IMAX Stock Is Looking Better Than Ever

IMAX stock's recent momentum is great, but it means you need to get in before it’s too late. The sky's the limit for this innovative company.

Fitbit Inc: Why FIT Stock Is Still Running for Its Life

Fitbit earnings were better than anyone expected, but as long as traders take their cues from the Street, FIT stock prices will take a long time to reflect the company’s actual value.

GrubHub Inc (GRUB): One Step Forward, Now Two Big Steps Behind

Grubhub (GRUB) is quite the gamble, has quite a lot of competitors to fend off and now has a nice hole to dig out of. The stock may not be done for good, but it’s best to get more tangible proof of progress before going long.

Tesla Motors Inc (TSLA): Perils of Breaking Into the Mass Market

Tesla vehicles hold a special place among buyers for both their tech and their electric nature, but TSLA stock may have to work harder for that next step.

Valeant Pharmaceuticals Intl Inc: Does VRX Have Enough to Survive?

VRX stock is taking steps in the right direction, but if Valeant can turn itself around, it won't happen overnight.

Microsoft Corporation (MSFT): There’s a Comeback in the Distance

As more evidence of cloud progress shows up in subsequent earnings reports - which it will - investors will remember all Microsoft (MSFT) has to offer, such as long-time tech experience and an impressive dedication to shareholders.